SARS‐CoV‐2–related ARDS in a maintenance hemodialysis patient: case report on tailored approach by daily hemodialysis, noninvasive ventilation, tocilizumab, anxiolytics, and point‐of‐care ultrasound

Without rescue drugs approved, holistic approach by daily hemodialysis, noninvasive ventilation, anti‐inflammatory medications, fluid assessment by bedside ultrasound, and anxiolytics improved outcomes of a maintenance hemodialysis patient affected by severe COVID‐19. Without rescue drugs approved,...

Full description

Saved in:
Bibliographic Details
Published in:Clinical case reports Vol. 9; no. 2; pp. 694 - 703
Main Authors: Galassi, Andrea, Casanova, Francesca, Gazzola, Lidia, Rinaldo, Rocco, Ceresa, Marco, Restelli, Elena, Giorgini, Alessia, Birocchi, Simone, Giovenzana, Marco, Zoni, Ulisse, Valli, Federica, Massironi, Laura, Belletti, Sebastiano, Magagnoli, Lorenza, Stucchi, Andrea, Ippolito, Michela, Carugo, Stefano, Parazzini, Elena, Cozzolino, Mario
Format: Journal Article
Language:English
Published: England John Wiley & Sons, Inc 01.02.2021
John Wiley and Sons Inc
Wiley
Subjects:
Anxiety
Blood pressure
Case Report
Case Reports
COVID‐19
Emergency medical care
expanded hemodialysis
Fever
Fistula
Hemodialysis
Hydration
Intensive care
Medical imaging
Monoclonal antibodies
Patients
Pleural effusion
Pneumonia
Point of care testing
point‐of‐care ultrasound
Respiratory distress syndrome
suprahepatic veins venogram
Thorax
tocilizumab
Ultrasonic imaging
Veins & arteries
Ventilators
hemodialysis
suprahepatic veins venogram
tocilizumab
COVID‐19
expanded hemodialysis
point‐of‐care ultrasound
ISSN:2050-0904, 2050-0904
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Without rescue drugs approved, holistic approach by daily hemodialysis, noninvasive ventilation, anti‐inflammatory medications, fluid assessment by bedside ultrasound, and anxiolytics improved outcomes of a maintenance hemodialysis patient affected by severe COVID‐19. Without rescue drugs approved, holistic approach by daily hemodialysis, noninvasive ventilation, anti‐inflammatory medications, fluid assessment by bedside ultrasound, and anxiolytics improved outcomes of a maintenance hemodialysis patient affected by severe COVID‐19.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Report-3
ObjectType-Case Study-4
ObjectType-Case Study-2
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:2050-0904
2050-0904
DOI:10.1002/ccr3.3623